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Abstract
Aims/hypothesis Intake of dietary fibre has been associated
with a reduced risk of type 2 diabetes, but few European
studies have been published on this. We evaluated the associ-
ation between intake of dietary fibre and type 2 diabetes in the
European Prospective Investigation into Cancer and Nutrition
(EPIC)-InterAct study and in a meta-analysis of prospective
studies.
Methods During 10.8 years of follow-up, 11,559 participants
with type 2 diabetes were identified and a subcohort of 15,258
participants was selected for the case-cohort study. Country-
specific HRs were estimated using Prentice-weighted Cox
proportional hazards models and were pooled using a random
effects meta-analysis. Eighteen other cohort studies were iden-
tified for the meta-analysis.
Results In the EPIC-InterAct Study, dietary fibre intake was
associated with a lower risk of diabetes (HRQ4 vs Q1 0.82; 95%
CI 0.69, 0.97) after adjustment for lifestyle and dietary factors.
Similar inverse associations were observed for the intake of
cereal fibre and vegetable fibre, but not fruit fibre. The asso-
ciations were attenuated and no longer statistically significant
after adjustment for BMI. In the meta-analysis (19 cohorts),
the summary RRs per 10 g/day increase in intake were 0.91
(95% CI 0.87, 0.96) for total fibre, 0.75 (95% CI 0.65, 0.86)
for cereal fibre, 0.95 (95% CI 0.87, 1.03) for fruit fibre and
0.93 (95% CI 0.82, 1.05) for vegetable fibre.
Conclusions/interpretation The overall evidence indicates
that the intake of total and cereal fibre is inversely related to
the risk of type 2 diabetes. The results of the EPIC-InterAct
Study suggest that the association may be partially explained
by body weight.
Keywords Case-cohort . Dietary fibre . EPIC-InterAct .
Meta-analysis . Type 2 diabetes
Abbreviation
EPIC European Prospective Investigation into Nutrition
and Cancer
Introduction
Worldwide, there is an increasing prevalence of type 2 diabe-
tes [1], which is likely to be driven by increasing adiposity,
reduced physical activity and dietary changes. The number of
people living with diabetes (mostly type 2 diabetes) world-
wide has been projected to increase from 366 million in
2011 to 552 million by 2030 [1], and this trend will have
important public health implications in terms of morbidity
[2], mortality [2, 3] and healthcare costs [4].
The intake of dietary fibre, especially of cereal origin, has
been inversely associated with risk of diabetes, as has been
summarised in a meta-analysis of cohort studies by Schulze
et al [5]. A higher intake of cereal fibre was associated with a
33% lower risk of diabetes compared with a low intake [5].
However, most of the studies included in this meta-analysis
were from the USA, and the level and sources of fibre intake
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may differ substantially between countries. For example, in
European populations [6, 7] total fibre intake appears to be
higher than that reported in several US studies [8–10], and this
may partly be explained by a higher intake of cereal fibre in
Europe compared with the US [6, 8–10]. It is also not clear
why cereal fibre could exert more beneficial effects on type 2
diabetes than other sources of fibre. Most cereals contain pro-
portionally larger amounts of insoluble fibre, while most evi-
dence from experimental studies on the benefits of fibre has
been accumulated for soluble fibres [11]. The aims of this
study were to evaluate the associations between total, cereal,
fruit and vegetable fibre and the incidence of type 2 diabetes in
a large European cohort, the European Prospective
Investigation into Cancer and Nutrition (EPIC)-InterAct
Study, and to summarise the existing evidence on fibre intake
and type 2 diabetes in a meta-analysis of prospective studies.
Methods
Study population
The EPIC-InterAct Study is embedded in EPIC, which is a
multicentre prospective cohort study designed to investigate
the relationship between food habits, nutritional status, vari-
ous lifestyle and environmental factors, and the incidence of
cancer and other chronic diseases in ten European countries
[12, 13]. The EPIC-InterAct Study used data from eight
European countries (Denmark, France, Germany, Italy, the
Netherlands, Spain, Sweden and the UK) [14]. We used a
nested case-cohort design, including incident cases of type 2
diabetes (n=12,403) and a random subcohort (n=16,835, in-
cluding 778 cases of incident diabetes), selected from 340,234
EPIC participants eligible for the EPIC-InterAct Study. All the
participants gave written informed consent, and the study was
approved by the local ethics committee at the participating
centres and the Internal Review Board of the International
Agency for Research on Cancer.
Population for current analysis
Of the 28,460 participants in the EPIC-InterAct nested case-
cohort sample, we excluded participants with prevalent diabe-
tes (n=548), missing information on reported diabetes status
(n=129), post-censoring diabetes (n=4), extreme energy in-
take (in the top 1% and bottom 1% of the distribution of the
ratio of reported energy intake over estimated energy require-
ment, assessed by basal metabolic rate; n=736), and partici-
pants with missing values for educational level (n=479),
physical activity (n=180), smoking status (n=131) and BMI
(n=165). This left a final sample of 11,559 cases and 15,258
subcohort participants (729 of the diabetes cases being from
the subcohort), for the current analysis (a total of 26,088
participants). No differences were observed in baseline char-
acteristics between the included and excluded participants.
Incidence of diabetes
Incident cases of diabetes were identified on the basis of self-
reporting, a linkage to primary care registers or secondary care
registers, medication use, hospital admissions and mortality
data [14]. The identified cases were verified with further evi-
dence, including individual medical record reviews. Cases in
Denmark and Sweden were not ascertained by self-reporting
but were identified via local and national diabetes and phar-
maceutical registers. Follow-up was censored at the date of
diagnosis, 31 December 2007 or the date of death, whichever
occurred first. In total, 11,559 verified incident cases were
identified during follow-up and were eligible for the current
analysis.
Fibre intake and other dietary variables
Dietary intake over the previous 12months before recruitment
was assessed by country-specific or centre-specific dietary
assessment methods (food frequency questionnaires and diet-
ary histories) that were developed and validated locally [12,
15, 16]. The food intake data were converted to nutrient intake
using the European Nutrient Database [17]. The method for
estimating total dietary fibre intake has previously been de-
scribed [18]. In brief, the gravimetric method of the
Association of Official Analytical Chemists [19] was used
for estimating the total dietary fibre (which includes soluble
and insoluble forms of non-starch polysaccharides and
resistant starch as fibre) in all countries except the UK,
where total dietary fibre was estimated by the Englyst
method (which includes non-starch polysaccharides but
not lignin or resistant starch). For the present study, we
used measurements of total dietary fibre and fibre from
cereals, fruits and vegetables, which are the main fibre
sources in all eight countries.
Lifestyle variables
Baseline information on lifestyle factors was obtained from
questionnaires. Weight, height and waist circumference were
measured by trained staff during standardised health checks at
baseline in all centres, except for a proportion of participants
in Oxford (UK) and France, for whom self-reported data were
obtained, and Umeå (Sweden), where waist circumference
was not measured. Physical activity was assessed by question-
naire and was classified according to the Cambridge Physical
Activity Index [20, 21].
Diabetologia (2015) 58:1394–1408 1395
Statistical analysis
We examined the association by country between quarters of
the distribution of fibre intake in the subcohort (hereafter re-
ferred to as quartiles) adjusted for energy using the residual
method [22] and the incidence of type 2 diabetes using Cox
proportional hazard models modified for the case-cohort de-
sign according to the Prentice method [23]. The underlying
time metric was age. In order to adjust for time to follow-up,
the age at recruitment (1 year categories) was included as a
stratum variable. Country-specific HRs and 95% CIs were
pooled using random effects meta-analyses [24]. Between-
country heterogeneity was assessed using the I2 statistic, i.e.
the percentage of variation in the HR that was attributable to
between-country heterogeneity [25]. The significance of line-
ar trends across quartiles of total and different sources of fibre
was tested by assigning the median value of the quartile to
each participant and modelling these values as a continuous
variable.
Confounders were assessed at baseline and those included
in the models were age and sex (model 1), lifestyle and clas-
sical diabetes risk factors (model 2), dietary factors (model 3)
and BMI (model 4). Each model was additionally adjusted for
the preceding model. Lifestyle and classical diabetes risk fac-
tors included smoking status (never smoker, former smoker or
current smoker), physical activity level based on an index of
activity (inactive, moderately inactive, moderately active or
active) [20, 21], education level (low, secondary or high)
and alcohol intake (0=non-drinker, 1=0–12/0–6 g/day for
men and women, respectively, 2=12–24/6–12 g/day or 3≥
24/12 g/day). Dietary factors included the total energy intake
and the energy-adjusted intake of carbohydrates, magnesium,
vitamin B1 and saturated fatty acids (continuous). The final
model also adjusted for BMI (continuous). All models for
subgroups of fibre were mutually adjusted for each other.
Variables not included in the multivariable models because
they did not change the risk estimates are listed in the elec-
tronic supplementary material (ESM) methods. A number of
stratified and sensitivity analyses were conducted, and these
are described in the ESM methods.
Analyses were conducted in SAS version 9.2 (SAS
Institute, Cary, NC, USA), except for the meta-analyses,
which were conducted in Stata 11.0 (Stata, College Station,
TX, USA). A two-sided p value ≤0.05 was considered statis-
tically significant for all analyses.
Meta-analysis
We searched PubMed up to and including 24 January 2014 for
prospective studies of fibre intake and risk of type 2 diabetes
using the keywords ‘fiber’, ‘fibre’ and ‘diabetes’. Eighteen
cohorts (20 publications) [5–10, 26–39] in addition to the
present study were included in the analyses. More details of
the study selection and methods can be found in the ESM
methods. Random effects models were used to calculate sum-
mary RRs comparing the highest with the lowest category of
fibre intake and for the dose–response analysis [24]. Dose–
response analyses were conducted using the method described
by Greenland and Longnecker [40]. Non-linear dose–
response analyses were conducted using fractional polynomial
models [41], and a likelihood ratio test was used to test for non-
linearity [41]. We quantified the extent of heterogeneity by
using I2 [25]. We tested for small-study bias using Egger’s test
[42] and by inspecting the funnel plots. All statistical analyses
for the meta-analysis were conducted using the statistical
package STATA 11.0.
Results
The EPIC-InterAct Study
The study population consisted of 26,088 participants. The
average age at baseline in the subcohort (n=15,258) was
52.4±9.1 years. Participants who had a high fibre intake
(>26.4 g/day) were less likely to smoke, drank little alcohol
and were more physically active than those with a low fibre
intake (<18.9 g/day; Table 1). The proportion of men was
higher in the lowest quartile of fibre intake (50% men) than
in the next three quartiles (31–35%). Although the mean BMI
was slightly higher in participants with a higher fibre intake
(Table 1), this may have been confounded by country as fibre
intake was positively associated with BMI only in Spain and
the Netherlands, was not associated with BMI in Italy, and
was inversely associated with BMI in the remaining countries
(ESM Table 1).
The mean±SD fibre intake in the subcohort was 22.9±
6.2 g/day (ranging from 19.9 g/day in Sweden to 25.2 g/day
in Denmark; data not shown). Cereals were the main source of
fibre (38%) in all countries except France, where vegetables
were the main source of fibre. Of the cereal fibres, 81% orig-
inated from bread (ranging from 56% in the UK to 90% in
Germany), 8% from pasta and rice (with the highest amounts
in Italy [23%] and France [16%]) and 7% from breakfast
cereals (with the highest amount in the UK [28%]). Other
sources of fibre in consecutive order were fibre from fruits
and nuts (20%), vegetables (18%), potatoes and tubers (9%)
and legumes (5%). Cereal, fruit and vegetable fibres together
accounted for around 75% of total fibre in all countries (data
not shown).
During a median of 10.8 years of follow-up, we ascertained
11,559 incident cases of type 2 diabetes. After adjusting for
lifestyle factors and dietary factors, total fibre intake was as-
sociated with a lower risk of diabetes (HRQ4 vs Q1 0.82; 95%
CI 0.69, 0.97; p for trend=0.02; Table 2).When evaluating the
fibre sources, the highest vs the lowest quartile of intake of
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cereal fibre (HR 0.81; 95% CI 0.70, 0.93; p for trend <0.01)
and vegetable fibre (HR 0.84; 95% CI 0.74, 0.96; p for trend
<0.01) were inversely associated with the risk of diabetes, but
fruit fibre (HR 0.98; 95%CI 0.89, 1.08; p for trend=0.74) was
not associated with risk of diabetes. However, when the analy-
ses were additionally adjusted for BMI, the inverse associa-
tions were attenuated and no longer statistically significant.
When comparing the highest with the lowest quartile, the
Table 1 Study characteristics (mean ± SD, unless otherwise specified) in a random subcohort from the EPIC-InterAct study stratified by quartiles of
energy-adjusted total fibre intake (n=15,258)
Variable n Q1 Q2 Q3 Q4
Cutoffs (g/day) <18.9 18.9–<22.4 22.4–26.4 >26.4
Median (g/day) 16.3 20.7 24.2 29.7
Age (years) 15,258 52.0±9.4 52.2±9.1 52.6±9.0 52.8±8.7
Men (%) 15,258 50 35 31 35
Follow-up (years) 15,258 12.0±2.5 12.0±2.3 11.9±2.4 12.0±2.2
BMI (kg/m2) 15,258 25.8±4.0 26.0±4.2 26.2±4.2 26.2±4.3
BMI (% obese) 15,258 14 16 17 16
Waist circumference (cm)
Men 5,282 94.8±10.2 94.9±9.9 95.9±9.6 95.1±9.8
Women 8,963 80.1±11.4 81.0±10.9 81.7±11.0 81.9±11.3
First-degree relatives with diabetes (% yes)a 7,615 17 19 21 19
Smoking (% current) 15,258 37 26 23 18
Hypertension (% yes) 14,930 18 19 20 19
Hyperlipidaemia (% yes) 11,389 18 19 19 19
Myocardial infarction (% yes) 15,007 1.4 1.3 1.5 1.4
Angina (% yes) 10,078 1.7 1.8 2.3 2.4
Stroke (% yes) 14,036 0.9 0.9 0.8 0.8
Educational level (% high) 15,258 21 21 20 21
Physical activity (% inactive) 15,258 25 24 23 22
Postmenopausal women (%) 9,484 44 46 47 51
Dietary factors
Energy (kJ/day) 15,258 9,320±2,834 8,579±2,562 8,629±2,516 9,286±2,617
Fat (en%) 15,258 36.7 35.4 34.3 32.7
Saturated fatty acids 14.8 13.6 12.8 11.7
Monounsaturated fatty acids 13.8 13.5 13.0 12.4
Polyunsaturated fatty acid 5.4 5.6 5.7 5.7
Protein (en%) 15,258 16.5 17.0 17.3 17.4
Carbohydrates (en%) 15,258 40.6 43.35 45.1 47.0
Starch 21.6 23.7 24.5 25.4
Sugars 18.4 19.1 20.0 20.9
Magnesium (mg/day) 15,258 313±64 337±59 362±61 398±65
Cholesterol (mg/day) 15,258 373±125 352±105 337±104 314±113
Vitamin B1 (mg/day) 15,258 1.2±0.3 1.3±0.3 1.4±0.3 1.5±0.4
β-Carotene (mg/day) 15,258 1.9±1.3 2.6±1.6 3.1±1.9 4.4±3.8
Vitamin C (mg/day) 15,258 88±44 111±45 131±52 167±83
Vitamin E (mg/day) 15,258 10.1±4.1 11.5±3.9 12.0±4.1 13.1±4.9
GI (not energy adjusted) 15,258 56.6±4.1 55.9±3.8 55.9±3.8 55.8±3.9
GL (not energy adjusted) 15,258 128±47 124±44 130±43 145±47
Alcohol (g/day) median (P10; P90), not energy adjusted 15,258 12 (0; 58) 7 (0; 37) 5 (0; 31) 4 (0; 30)
Alcohol (% non-drinkers) 15,258 19 26 29 31
a Family history of diabetes was not ascertained in Italy, Spain, Oxford and Heidelberg (excluded from this summary)
en%, percentage of total energy intake; GI, glycaemic index; GL, glycaemic load; P10, 10th percentile; P90, 90th percentile
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HRs were 0.91 (95% CI 0.81, 1.03; p for trend=0.28) for total
fibre, 0.95 (95% CI 0.83, 1.08; p for trend=0.49) for cereal
fibre, 0.96 (95%CI 0.83, 1.10; p for trend=0.76) for fruit fibre
and 0.93 (95% CI 0.84, 1.03; p for trend=0.11) for vegetable
fibre. Adjustment for BMI explained 50% of the association
between total fibre and type 2 diabetes. We did not observe
substantial between-country heterogeneity for total fibre or
sources of fibre (I2=2.6%, 7.0%, 34.3% and 0% for total,
cereal, fruit and vegetable fibre, respectively; Fig. 1). The
association between dietary fibre and type 2 diabetes was
not modified by sex, BMI, physical activity, smoking, mag-
nesium intake, vitamin B1 intake, glycaemic index or
glycaemic load (all p>0.05). The results were not materially
altered in several sensitivity analyses (see ESM results).
Meta-analysis
Eighteen independent cohorts (20 publications) [5–10, 26–39]
in addition to the EPIC-InterAct study were included in the
meta-analysis, with a total of 617,968 participants and 41,066
incident cases of type 2 diabetes (Table 3, ESM Fig. 1). The
study characteristics of the cohorts are provided in Table 3. Of
the 19 cohort studies, eight were conducted in the USA, five in
Europe, three in Australia and three in Asia.
Total fibre Sixteen studies [6–10, 26, 28–30, 32–34, 36–39] in
addition to the EPIC-InterAct Study were included in the analy-
sis of total fibre and type 2 diabetes (36,578 cases among 572,
665 participants). Two of the studies [37, 38] were only includ-
ed in the analysis of the highest vs the lowest intake. The sum-
mary RR comparing the highest vs the lowest intake was 0.85
(95%CI 0.77, 0.94; I2 61.0%, pheterogeneity=0.002, n=13) (ESM
Fig. 2a), and in the dose–response analysis the summary RR per
10 g/day was 0.91 (95% CI 0.87, 0.96; I2 29.4%, pheterogeneity=
0.14, n=15) (Fig. 2a). There was no evidence of non-linearity,
with pnon-linearity=0.37 (Fig. 2b, ESM Table 2).
Cereal fibre Twelve studies (13 publications) [6, 8–10,
26–33, 35] in addition to the EPIC-InterAct Study were in-
cluded in the analysis (30,224 cases and 455,563 participants).
One of the studies [32] was only included in the analysis of the
highest vs the lowest intake. The summary RR for the highest
vs the lowest cereal fibre intake was 0.77 (95% CI 0.68, 0.87;
I2 77.7%, pheterogeneity<0.0001, n=12) (ESM Fig. 2b) and per
10 g/day was 0.75 (95%CI 0.65, 0.86; I2=75.1%, pheterogeneity
Table 2 HRs (95% CI) for the associations between quartiles of dietary fibre and incident type 2 diabetes in the EPIC-InterAct Study (n=26,088)
Variable Q1 Q2 Q3 Q4 p
Total fibre, g/day (median) <18.9 (16.3) 18.9–22.4 (20.7) 22.4–26.4 (24.2) >26.4 (29.7)
Model 1 ‘age, sex’ 1.00 0.91 (0.82, 1.02) 0.90 (0.79, 1.02) 0.93 (0.78, 1.11) 0.08
Model 2 ‘lifestyle’ 1.00 0.92 (0.82, 1.04) 0.91 (0.81, 1.02) 0.84 (0.69, 1.02) 0.07
Model 3 ‘lifestyle and diet’ 1.00 0.92 (0.83, 1.02) 0.91 (0.82, 1.01) 0.82 (0.69, 0.97) 0.02
Model 4 ‘lifestyle, diet and BMI’ 1.00 0.93 (0.84, 1.03) 0.98 (0.89, 1.08) 0.91 (0.81, 1.03) 0.28
Cereal fibre, g/day (median) <5.7 (4.3) 5.7–7.9 (6.8) 7.9–10.9 (9.3) >10.9 (13.7)
Model 1 ‘age, sex’ 1.00 0.89 (0.80, 0.99) 0.88 (0.77, 1.00) 0.85 (0.72, 1.00) 0.03
Model 2 ‘lifestyle’ 1.00 0.89 (0.80, 0.98) 0.89 (0.80, 0.99) 0.82 (0.72, 0.93) <0.01
Model 3 ‘lifestyle and diet’ 1.00 0.90 (0.80, 1.00) 0.91 (0.82, 1.00) 0.81 (0.70, 0.93) <0.01
Model 4 ‘lifestyle, diet, and BMI’ 1.00 0.90 (0.80, 1.02) 1.00 (0.90, 1.10) 0.95 (0.83, 1.08) 0.49
Fruit fibre, g/day (median) <2.3 (1.4) 2.3–4.0 (3.1) 4.0–6.6 (5.1) >6.3 (8.4)
Model 1 ‘age, sex’ 1.00 0.88 (0.82, 0.95) 0.91 (0.83, 1.00) 0.89 (0.81, 0.98) 0.17
Model 2 ‘lifestyle’ 1.00 0.91 (0.84, 0.98) 0.96 (0.88, 1.04) 0.93 (0.85, 1.01) 0.41
Model 3 ‘lifestyle and diet’ 1.00 0.93 (0.86, 1.00) 0.98 (0.90, 1.06) 0.98 (0.89, 1.08) 0.74
Model 4 ‘lifestyle, diet, and BMI’ 1.00 0.91 (0.82, 1.00) 0.93 (0.84, 1.03) 0.96 (0.83, 1.10) 0.76
Vegetable fibre, g/day (median) <2.4 (1.6) 2.4–3.6 (3.0) 3.6–5.3 (4.4) >5.3 (6.9)
Model 1 ‘age, sex’ 1.00 0.95 (0.88, 1.02) 0.87 (0.76, 0.98) 0.93 (0.78, 1.11) 0.57
Model 2 ‘lifestyle’ 1.00 0.98 (0.91, 1.06) 0.91 (0.81, 1.03) 0.98 (0.85, 1.14) 0.92
Model 3 ‘lifestyle and diet’ 1.00 0.94 (0.87, 1.01) 0.82 (0.71, 0.94) 0.84 (0.74, 0.96) <0.01
Model 4 ‘lifestyle, diet, and BMI’ 1.00 0.91 (0.84, 0.99) 0.83 (0.71, 0.97) 0.93 (0.84, 1.03) 0.11
Model 1 was adjusted for age and sex
Model 2 was additionally adjusted for lifestyle factors: smoking status, physical activity, education level and sex-specific alcohol categories
Model 3 was additionally adjusted for dietary factors: energy and energy-adjusted carbohydrates, magnesium, vitamin B1 and saturated fatty acids
Model 4 was additionally adjusted for BMI
All models for types of fibre were mutually adjusted
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<0.0001, n=12) (Fig. 2c). There was evidence of non-
linearity (pnon-linearity=0.004), with a steeper reduction in risk
at higher levels of fibre intake (Fig. 2d, ESM Table 2).
Fruit fibre Ten studies [6, 8–10, 26, 28–30, 33, 36] in addi-
tion to the EPIC-InterAct Study were included in the analysis
(25,715 cases among 408,416 participants). The summary RR
for the highest vs the lowest intake of fruit fibre was 0.95
(95% CI 0.88, 1.01; I2 16.9%, pheterogeneity=0.29, n=10)
(ESM Fig. 2c) and per 10 g/day was 0.95 (95% CI 0.87,
1.03, I2 31.1%, pheterogeneity=0.15, n=11) (Fig. 3a). There
was a suggestive non-linear association between fruit fibre
and risk of type 2 diabetes (pnon-linearity=0.04), with a slightly
steeper curve when increasing intake from low levels, but the
association was very weak (Fig. 3b, ESM Table 2).
Vegetable fibre Ten studies [6, 8–10, 26, 29, 30, 32, 33, 36] in
addition to the EPIC-InterAct Study were included in the analy-
sis (24,428 cases among 399,593 participants). One of the
studies [32] was only included in the analysis of the highest vs
the lowest intake. The summary RR for the highest vs the lowest
intake was 0.96 (95% CI 0.86, 1.07; I2 48.3%, pheterogeneity=
0.04, n=10) (ESM Fig. 2d) and per 10 g/day was 0.93 (95%
CI 0.82, 1.05; I2=43.5%, pheterogeneity=0.07, n=10) (Fig. 3c).
There was evidence of a non-linear association between vegeta-
ble fibre and risk of type 2 diabetes, (pnon-linearity<0.0001), with
an inverse association restricted to a very high intake (12–14 g/
day) (Fig. 3d, ESM Table 2).
Soluble and insoluble fibre Only three studies [5, 6, 10]
investigated the intake of soluble and insoluble fibre and risk
of diabetes (2,141 cases among 65,373 participants). The
summary RR for the highest vs the lowest intake was 0.85
(95% CI 0.72, 1.01; I2=41.9%, pheterogeneity=0.18) for soluble
fibre and 0.75 (95% CI 0.57, 0.97; I2=0%, pheterogeneity=0.44)
(ESM Fig. 3a, b) for insoluble fibre. In the dose–response
analysis, the summary RR per 10 g/day was 0.70 (95% CI
0.47, 1.04; I2=0%, pheterogeneity=0.50) for soluble fibre and
0.73 (95% CI 0.62, 0.86; I2=0%, pheterogeneity=0.46) for insol-
uble fibre (ESM Fig. 3c, d).
Subgroup, sensitivity analyses and publication bias The
results were in general consistent across the strata in the sub-
group (ESM Tables 3 and 4) and sensitivity analyses (ESM
results). Most of the studies adjusted for BMI, and the results
persisted among studies that adjusted for BMI (ESM Tables 3
and 4). In the analysis of cereal fibre there was a suggestion of
small-study bias with Egger’s test (p=0.08) and asymmetry in
the funnel plot suggesting that smaller studies with positive
associations were missing (ESM Fig. 4). When restricting the
analysis to four studies [10, 28, 31, 33] and the EPIC-InterAct
study that had ≥1,000 cases, Egger’s test was no longer signif-
icant (p=0.25), but the inverse association was similar to the
overall analysis (summary RR 0.76; 95% CI 0.63, 0.92;
I2=81.0%, pheterogeneity<0.0001). There was no evidence of
publication bias for total fibre, fruit fibre or vegetable fibre
(p=0.16, p=0.73 and p=0.74, respectively).
Discussion
The EPIC-InterAct study showed that a high intake of total
fibre compared with a low intake was associated with an 18%
lower risk of incident type 2 diabetes when adjusted for life-
style and dietary factors. This was mainly driven by the intake
of cereal fibre and vegetable fibre, and not by fruit fibre.When
.
.
.
.
Total fibre
France
Italy
Spain
UK
Netherlands
Germany
Sweden
Denmark
Subtotal  (I2=2.6%, p=0.410)
Cereal fibre
France
Italy
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Netherlands
Germany
Sweden
Denmark
Subtotal  (I2=7.0%, p=0.376)
Fruit fibre
France
Italy
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UK
Netherlands
Germany
Sweden
Denmark
Subtotal  (I2=34.3%, p=0.154)
Vegetable fibre
France
Italy
Spain
UK
Netherlands
Germany
Sweden
Denmark
Subtotal  (I2=0.0%, p=0.812)
Country
0.99 (0.54, 1.83)
0.90 (0.64, 1.26)
1.13 (0.89, 1.44)
0.82 (0.53, 1.27)
1.00 (0.59, 1.68)
0.83 (0.59, 1.15)
1.00 (0.74, 1.34)
0.73 (0.57, 0.94)
0.91 (0.81, 1.03)
1.72 (0.70, 4.22)
1.13 (0.76, 1.67)
1.12 (0.83, 1.50)
0.74 (0.49, 1.11)
1.07 (0.67, 1.71)
0.76 (0.56, 1.04)
0.96 (0.76, 1.22)
0.87 (0.60, 1.24)
0.95 (0.83, 1.08)
1.14 (0.65, 1.98)
1.44 (0.98, 2.12)
0.98 (0.81, 1.20)
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0.84 (0.66, 1.06)
0.96 (0.83, 1.10)
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0.96 (0.80, 1.16)
0.60 (0.37, 0.97)
0.90 (0.59, 1.38)
0.88 (0.59, 1.33)
0.93 (0.71, 1.23)
0.99 (0.79, 1.24)
0.93 (0.84, 1.03)
HR (95% CI)
0.25 0.5 1.0 2.0 3.0 5.0
HR
Fig. 1 Association between cereal fibre, fruit fibre and vegetable fibre
consumption and risk of type 2 diabetes in the EPIC-InterAct study (n=
26,088). Country-specific HRQ4 vs Q1 (95% CIs) were pooled using ran-
dom effects meta-analysis. HRs were adjusted for sex, smoking status,
physical activity, education level, sex-specific alcohol categories, energy,
energy-adjusted carbohydrate, magnesium intake, vitamin B1 intake, sat-
urated fatty acids and BMI. The x-axis is on a log scale
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the results were adjusted for BMI, total fibre and cereal and
vegetable fibre were not significantly associated with risk of
type 2 diabetes. However, the findings from our updatedmeta-
analysis of prospective studies do support an inverse associa-
tion between total fibre and cereal fibre intake and risk of type
2 diabetes, with a 9% and 25% lower RR per 10 g/day, respec-
tively, independent of BMI. A stronger inverse association
between cereal fibre intake and type 2 diabetes than for fruit
or vegetable fibre is consistent with previous meta-analyses of
fibre intake and type 2 diabetes [5, 43], and with recent meta-
analyses that have shown stronger associations for whole
grain intake [44] than for fruit and vegetable intake in relation
to risk of type 2 diabetes [45]. Differences in the strength and
shape of the dose–response relationship compared with the
previous meta-analyses [5, 43] may be due to the larger num-
ber of studies that was included in the present dose–response
analyses and the addition of the EPIC-InterAct data. For
example, in the linear dose–response analysis of dietary fibre,
we included seven additional studies [6–8, 26, 33, 34, 39] as
well as the present EPIC-InterAct study.
It has been suggested that the beneficial effect of cereal
fibre observed in many studies could be explained by other
nutrients co-ingested with the fibre, for example magnesium
and vitamins such as B1, C and E [46]. In the EPIC-InterAct
study, adding these nutrients to the models did not materially
alter the association with cereal fibre. It is also possible that the
low glycaemic index of diets high in total or cereal fibre could
explain the relationship between fibre intake and diabetes. A
low glycaemic index could lead to a lower postprandial glu-
cose peak, which leads to a decreased insulin demand and
protects the pancreas from exhaustion [47]. However, no as-
sociation was observed between the glycaemic index or
glycaemic load and diabetes in the EPIC-InterAct study
[48], and further adjustment for both glycaemic index
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Fig. 2 Dietary total fibre (a, b) and cereal fibre (c, d) and type 2 diabetes,
linear dose–response meta-analyses per 10 g/day (a, c) and non-linear
dose–response meta-analyses (b, d). In (a) and (c), the RR of each study
is represented by a square, and the size of the square represents the weight
of each study to the overall estimate. The 95% CIs are represented by
horizontal lines, and the diamond represents the overall estimate and its
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and glycaemic load did not change our results. This is
consistent with other studies that have found little im-
pact of additional adjustments for glycaemic index,
glycaemic load and/or magnesium intake [9, 31, 34].
The intake of fruit fibre was not associated with type
2 diabetes in any of the models, but it is not clear why
this is as the range of fruit fibre intake was comparable
to that of other studies.
Our study has some limitations that could have affected the
results. Measurement error in the assessment of dietary intake
by questionnaire may have attenuated an association between
fibre intake and type 2 diabetes. Different degrees of measure-
ment error in the assessment of subtypes of fibre intake might
explain the different magnitude of association observed with
these subtypes. Dietary intake was assessed only at baseline,
so we were not able to take into account dietary changes
during follow-up. The strengths of the EPIC-InterAct study
include the prospective design, the large number of
cases, the extensive and validated dietary questionnaires,
the wide range of dietary fibre intake in eight countries
with a large variation in the different sources of fibre
intake, and the detailed information on other potential
confounders, including height and weight, which were
measured in most of the study participants and may
have reduced potential confounding by adiposity.
We cannot exclude the possibility that the inverse associa-
tions for total fibre and cereal fibre intake in the meta-analysis
could be due to residual confounding as fibre intake has been
associated with a healthier overall dietary pattern, a lower
BMI and higher physical activity [6, 9, 10, 31]. Althoughmost
studies adjusted for BMI, physical activity, alcohol, smoking
and energy intake, relatively few studies adjusted for other
dietary factors. However, in the EPIC-InterAct study, adjust-
ment for other dietary factors did not substantially alter the risk
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estimates. It is not clear why our result differs from the result of
the meta-analysis. Weight and height were measured (rather
than self-reported) in EPIC-InterAct. In general, adjustment
for confounding with an imperfect measure of that confounder
leads to the possibility of residual confounding. This is possible
in this context as some other studies have used more imprecise
measures, such as self-reported BMI, and could therefore have
more issues with residual confounding. Of 11 studies of cereal
fibre that adjusted for BMI, all six studies with self-reported
weight and height reported inverse associations [8–10, 26, 31,
33], while only two [6, 28] out of five of the studies [6, 28, 29,
35] (including EPIC-InterAct) with measured weight and
height reported significant inverse associations. However, data
for other fibre types and total fibre do not appear to vary by
whether weight and height was measured or self-reported, so
chance can also not be excluded as an explanation.
In the meta-analysis of cereal fibre, there was some sugges-
tion of small-study bias. However, when the analysis was
restricted to studies with a large number of cases (≥1,000),
there was no evidence of asymmetry in the funnel plot and
Egger’s test was no longer significant, although the summary
estimate was similar to that of the overall analysis.
The attenuation of the inverse associations we observed
between total fibre, cereal fibre and vegetable fibre and diabe-
tes after adjustment for BMI in the EPIC-InterAct analysis
suggests that the beneficial effect of fibre may be partly me-
diated by a lower BMI, and this is consistent with other studies
[5, 33]. A previous analysis in the EPIC study found an in-
verse association between fibre intake, particularly cereal fibre
intake, and changes in weight and waist circumference [49],
and other studies have also shown an inverse association be-
tween fibre intake and overweight, obesity, weight gain or
visceral adiposity [50–54], although the data are not convinc-
ing [55]. However, as the observed effects of fibre intake on
adiposity and weight change are relatively modest, BMI may
act as both a confounder and a mediator in the relationship
between fibre intake and diabetes. Dietary fibre may affect
appetite and energy intake through a range of processes in-
cluding a delayed emptying rate, a prolonged release of hor-
monal signals, a slowing of nutrient absorption or altered fer-
mentation in the large intestine [51, 56].
Apart from reduced adiposity, dietary fibre may affect the
risk of diabetes by other mechanisms as well. Dietary fibre
intake improves glycaemic control by decreasing postprandial
glycaemia and insulinaemia, and increases insulin sensitivity
[57, 58]. There is also a cross-sectional association between
the consumption of high-fibre breakfasts and markers of diabe-
tes risk in children [59]. The fermentation of dietary fibres in
the large intestine may alter the growth of specific gut bacteria,
affect the production and composition of short-chain fatty acids
and thereby affect the secretion of appetite-regulating peptides
[60]. Furthermore, fermentable fibres may regulate the uptake
of energy from the gut by the production or activation of
signalling molecules involved in the host’s metabolism, a mod-
ification of gut permeability, the release of gut hormones and
inflammation [61]. Based on intervention studies, the effect on
glycaemic control appears to be stronger for soluble fibre than
for insoluble fibre [62, 63], while in the meta-analysis we found
an association with insoluble fibre and cereal fibre (which is
high in insoluble fibre), but not with soluble fibre. Limited
statistical power because of the low number of studies might
explain the lack of association for soluble fibre as the risk
estimates were of similar size, but further studies are needed
to clarify whether there is a difference in the association be-
tween soluble and insoluble fibre and risk of diabetes.
In several, but not all, studies [64, 65], dietary fibre, cereal
fibre and whole grains have been associated with lower concen-
trations of inflammatory markers [66–69], serum uric acid [70]
and γ-glutamyltransferase [67, 71], markers that have been asso-
ciated with increased risk of diabetes [72–74] and higher concen-
trations of adiponectin [75–77], an adipocyte-secreted cytokine
that increases insulin sensitivity and may reduce risk of diabetes
[78]. Alternatively, it is possible that other components of foods
rich in cereal fibre such as whole grains could contribute to the
reduced risk of diabetes by as yet unidentified mechanisms.
In summary, inverse associations were observed between
the intake of total, cereal and vegetable fibre and risk of type
2 diabetes in the EPIC-InterAct study, but these associations
were no longer significant after adjustment for BMI. In an up-
to-date meta-analysis of all published prospective studies, we
found an inverse association between total fibre and cereal fibre
and risk of type 2 diabetes independent of BMI. Taken together,
the results indicate that individuals with a diet rich in fibre,
especially cereal fibre, may have a lower risk of type 2 diabetes.
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